
Proving the impact through structured trials and data-driven insights
Structured trial demonstrating dosing control benefits
Flocculants play a vital role in thickener performance. This case study explores how CFT demonstrated the benefits of controlled flocculant dosing through a structured trial, leading to clearer operational insights and improved reliability.
Prior to the trial, flocculant dosing was inconsistent, leading to:
Data showed significant inconsistencies, particularly between flocculant dosing and mixing tank levels, indicating systemic inefficiencies.
Flocculant dosage was carefully regulated at two primary setpoints, improving stability and predictability.
Consistent flocculant dosing is crucial for stable thickener operation. The trial provided actionable evidence for implementing long-term dosing controls.